Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Life Science Alliance|May 31, 2022
MET∆14 promotes a ligand-dependent, AKT-driven invasive growthMarina Cerqua, Orsola Botti, Maddalena Arigoni, et al.
Molecular Oncology|October 13, 2014
TNF-α promotes invasive growth through the MET signaling pathwayViola Bigatto, Francesca De Bacco, Elena Casanova, et al.
Stem Cells (Dayton, Ohio)|September 13, 2017
Genetic Evolution of Glioblastoma Stem-Like Cells From Primary to Recurrent TumorFrancesca Orzan, Francesca De Bacco, Giovanni Crisafulli, et al.
Critical Reviews in Oncology/Hematology|February 2, 2020
Cerebrospinal fluid tumor DNA for liquid biopsy in glioma patients' management: Close to the clinic?Matteo Simonelli, Angelo Dipasquale, Francesca Orzan, et al.
EMBO Molecular Medicine|June 9, 2020
Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case reportSilvia Benvenuti, Melissa Milan, Elena Geuna, et al.
British Journal of Pharmacology|March 6, 2020
Activation of the MET receptor attenuates doxorubicin-induced cardiotoxicity in vivo and in vitroSimona Gallo, Martina Spilinga, Raffaella Albano, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2011
Wild-type p53 controls cell motility and invasion by dual regulation of MET expressionChang-Il Hwang, Andres Matoso, David C Corney, et al.
Cell Death Discovery|May 21, 2025
Androgen receptor inhibition sensitizes glioblastoma stem cells to temozolomide by the miR-1/miR-26a-1/miR-487b signature mediated WT1 and FOXA1 silencingAna Belén Díaz Méndez, Marta Di Giuliani, Andrea Sacconi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2017
A Molecularly Annotated Model of Patient-Derived Colon Cancer Stem-Like Cells to Assess Genetic and Nongenetic Mechanisms of Resistance to Anti-EGFR TherapyPaolo Luraghi, Viola Bigatto, Elia Cipriano, et al.
Molecular Oncology|March 2, 2023
MicroRNA 483-3p overexpression unleashes invasive growth of metastatic colorectal cancer via NDRG1 downregulation and ensuing activation of the ERBB3/AKT axisErmes Candiello, Gigliola Reato, Federica Verginelli, et al.
Pageof 5